FANZANI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 6.828
EU - Europa 3.691
AS - Asia 3.330
SA - Sud America 478
AF - Africa 76
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 4
Totale 14.421
Nazione #
US - Stati Uniti d'America 6.709
PL - Polonia 1.203
SG - Singapore 1.186
CN - Cina 1.092
IT - Italia 609
UA - Ucraina 515
BR - Brasile 394
DE - Germania 379
HK - Hong Kong 337
FI - Finlandia 240
GB - Regno Unito 237
VN - Vietnam 192
FR - Francia 148
IN - India 136
TR - Turchia 108
RU - Federazione Russa 99
IE - Irlanda 89
CA - Canada 57
BD - Bangladesh 50
JP - Giappone 47
MX - Messico 35
AR - Argentina 32
IQ - Iraq 31
ID - Indonesia 29
CZ - Repubblica Ceca 27
NL - Olanda 25
ES - Italia 23
SA - Arabia Saudita 21
SE - Svezia 21
ZA - Sudafrica 21
BE - Belgio 18
EG - Egitto 14
AT - Austria 13
AU - Australia 13
EC - Ecuador 12
CO - Colombia 11
UZ - Uzbekistan 11
VE - Venezuela 11
KE - Kenya 9
NG - Nigeria 9
IR - Iran 8
PK - Pakistan 8
AE - Emirati Arabi Uniti 7
CH - Svizzera 7
KR - Corea 7
KZ - Kazakistan 7
MA - Marocco 7
JM - Giamaica 6
PA - Panama 6
AL - Albania 5
DK - Danimarca 5
JO - Giordania 5
MY - Malesia 5
PY - Paraguay 5
DZ - Algeria 4
EU - Europa 4
KG - Kirghizistan 4
LT - Lituania 4
LV - Lettonia 4
PE - Perù 4
PH - Filippine 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
CL - Cile 3
IL - Israele 3
LA - Repubblica Popolare Democratica del Laos 3
MU - Mauritius 3
OM - Oman 3
RO - Romania 3
AM - Armenia 2
AZ - Azerbaigian 2
BB - Barbados 2
BO - Bolivia 2
CR - Costa Rica 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
GY - Guiana 2
HN - Honduras 2
HU - Ungheria 2
KW - Kuwait 2
NI - Nicaragua 2
PS - Palestinian Territory 2
PT - Portogallo 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
CG - Congo 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
Totale 14.408
Città #
Warsaw 1.201
Ashburn 645
Singapore 623
Fairfield 620
Woodbridge 508
San Jose 449
Jacksonville 369
Hong Kong 334
Houston 307
Beijing 247
Cambridge 243
Brescia 235
Seattle 235
Chandler 218
Wilmington 218
New York 196
Ann Arbor 193
The Dalles 180
Los Angeles 157
Princeton 157
Nanjing 132
Chicago 131
Helsinki 130
Lauterbourg 93
Lancaster 90
Dublin 89
Istanbul 85
Council Bluffs 74
Milan 68
Munich 67
Buffalo 64
Dearborn 62
Jinan 56
Salt Lake City 55
Des Moines 54
Dallas 53
Shenyang 51
Nanchang 48
Hanoi 44
Ho Chi Minh City 44
San Francisco 42
Shanghai 41
Hebei 38
Redondo Beach 36
Moscow 35
Tianjin 35
Dong Ket 34
Changsha 33
Elk Grove Village 32
Turku 31
Verona 30
Orem 29
Santa Clara 29
San Diego 28
São Paulo 27
London 26
Brooklyn 25
Denver 24
Jakarta 24
Boston 22
Phoenix 22
Tampa 22
Ningbo 20
Hangzhou 19
Rome 19
Taizhou 18
Atlanta 17
Brussels 17
Stockholm 17
Tokyo 17
Baghdad 16
Frankfurt am Main 16
Manchester 16
Nuremberg 16
Johannesburg 15
New Delhi 15
Olomouc 15
Urbino 15
Zhengzhou 15
Chennai 14
Kunming 14
Poplar 14
Salerno 14
Toronto 14
Dhaka 13
Lappeenranta 13
Montreal 13
Boardman 12
Charlotte 12
Mexico City 12
Ottawa 12
San Mateo 12
Taiyuan 12
Brno 11
Guangzhou 11
Miami 11
Sterling 11
Washington 11
Mumbai 10
Norwalk 10
Totale 10.029
Nome #
MURC/cavin-4 is co-expressed with Caveolin-3 in rhabdomyosarcoma tumors and its silencing prevents myogenic differentiation in the human embryonal RD cell line 596
Inhibition of glutathione peroxidase 4 primes mouse C2C12 myoblasts and rhabdomyosarcoma cell lines to ferroptosis 335
Characterization of the AP-1 μ1A and μ1B adaptins in zebrafish (Danio rerio) 310
Iron, Oxidative Damage and Ferroptosis in Rhabdomyosarcoma. 284
Caveolin-3, MURC and Trim72 predict myogenic differentiation in the human embryonal rhabdomyosarcoma RD cell line 283
Caveolin-1 overexpression in the human embryonal rhabdomyosarcoma RD cells increases tumor growth and metastasis in vivo through a phospho-ERK-dependent signaling pathway 271
Caveolin-1 overexpression accelerates tumor growth and metastasis of embryonal rhabdomyosarcoma 261
Melatonin action in tumor skeletal muscle cells: an ultrastructural study 257
Intake of Special Amino Acids Mixture Leads to Blunted Murine Colon Cancer Growth In Vitro and In Vivo 248
Caveolin-1, Caveolin-2 and Cavin-1 are strong predictors of adipogenic differentiation in human tumors and cell lines of liposarcoma 230
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma 220
Urocortin Induces Phosphorylation of Distinct Residues of Signal Transducer and Activator of Transcription 3 (STAT3) via Different Signaling Pathways 210
Caveolin 1 is a marker of poor differentiation in Rhabdomyosarcoma 203
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma. 201
The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells 197
Cobalt triggers necrotic cell death and atrophy in skeletal C2C12 myotubes 195
Melatonin effects in normal and tumoral skeletal muscle cells: a preliminary study 193
MURC/cavin-4 is co-expressed with Caveolin-3 in rhabdomyosarcoma tumors and its silencing prevents myogenic differentiation in the human embryonal RD cell line 193
Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines 190
Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation 187
Cisplatin triggers atrophy of skeletal C2C12 myotubes via impairment of Akt signalling pathway and subsequent increment activity of proteasome and autophagy systems 185
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma 185
Erastin is a strong inducer of ferroptosis in human rhabdomyosarcoma cell lines 177
The cytosolic sialidase Neu2 is degraded by autophagy during myoblast atrophy. 174
Cytosolic sialidase Neu2 upregulation during PC12 cells differentiation. 171
Caveolin-1-overexpression induces deep plasma membrane rearrangement and secretion of extracellular vesicles in a model of rhabdomyosarcoma 171
Implications for the mammalian sialidases in the physiopathology of skeletal muscle 169
Animal models of well-differentiated/dedifferentiated liposarcoma: utility and limitations 169
Rhabdomyosarcomas: an overview on the experimental animal models. 167
Hypertrophy and atrophy inversely regulate Caveolin-3 expression in myoblasts 165
CAVEOLIN-1 IS A MARKER OF POOR DIFFERENTIATION IN RHABDOMYOSARCOMA 165
Point mutated Caveolin-3 form (P104L) impairs myoblast differentiation via Akt and p38 signalling reduction, leading to an immature cell signature 164
Biochemical characterization of Neu2, a novel human cytosolic sialidase 156
Phenotypic behavior of C2C12 myoblasts upon expression of the dystrophy-related caveolin-3 P104L and TFT mutants 155
Autophagic degradation contributes to muscle wasting in cancer cachexia 155
Defective myogenic differentiation of human rhabdomyosarcoma cells is characterized by sialidase Neu2 loss of expression. 154
Overexpression of cytosolic sialidase Neu2 induces myoblast differentiation in C2C12 cells. 154
Uncovering metabolism in rhabdomyosarcoma 154
Clozapine-induced alteration of glucose homeostasis in the rat: the contribution of hypothalamic-pituitary-adrenal axis activation 153
The enzymatic activity of sialidase Neu2 is inversely regulated during in vitro myoblast hypertrophy and atrophy. 152
Caveolins in rhabdomyosarcoma 150
Cavin-2 is a specific marker for detection of well-differentiated liposarcoma. 149
Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair 149
OVEREXPRESSION OF CYTOSOLIC SIALIDASE NEU2 INDUCES MYOBLAST DIFFERENTIATION IN C2C12 CELLS 148
Insulin-like growth factor 1 signaling regulates cytosolic sialidase Neu2 expression during myoblast differentiation and hypertrophy. 143
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma 143
Focus on the role of Caveolin and Cavin protein families in liposarcoma 142
Molecular and cellular mechanisms of skeletal muscle atrophy: an update 140
Validation of PTRF/cavin-1 expression and plasma membrane association with caveolin-1 in human cell lines and mouse primary tumor cultures of rhabdomyosarcoma 140
Melatonin decreases cell proliferation, impairs myogenic differentiation and triggers apoptotic cell death in rhabdomyosarcoma cell lines 138
Design and optimization of lentiviral vectors for transfer of galc expression in twitcher brain 136
AUTOPHAGIC DEGRADATION CONTRIBUTES TO MUSCLE WASTING IN CANCER CACHEXIA 134
Muscular dystrophies share pathogenetic mechanisms with muscle sarcomas 134
OVEREXPRESSION OF CYTOSOLIC SIALIDASE NEU2 INDUCES MYOBLAST DIFFERENTIATION IN C2C12 CELLS 132
CAVEOLINS AND CAVINS IN MUSCLE-DERIVED TUMOURS 132
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 132
Intracellular vesicular traffic:cloning, expression and antisense inhibition of AP1m1 subunit ortholog in zebrafish 130
NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance 129
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 124
Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition. 123
Caveolin-1-overexpression induces extracellular vesicle secretion in a model of rhabdomyosarcoma 123
Guidelines for the use and interpretation of assays for monitoring autophagy 122
Clinically relevant radioresistant rhabdomyosarcoma cell lines: functional, molecular and immune-related characterization 122
IGF-I SIGNALING REGULATES CYTOSOLIC SIALIDASE NEU2 DURING MYOBLAST HYPERTROPHY. 119
CAVEOLIN-1 PROMOTES PROLIFERATION AND CONFERS RESISTANCE TO OXIDATIVE STRESS-INDUCED CELL DEATH IN RHABDOMYOSARCOMA CELLS 117
Involvment of sialidases in differentation of PC12 114
Generation and characterization of chemoresistant embryonal rhabdomyosarcoma RD line 111
Downregulation of Zebrafish Cytosolic Sialidase Neu3.2 Affects Skeletal Muscle Development 111
The cytosolic sialidase Neu2 is substrate of degradation by autophagy during myoblast atrophy 111
IGF-I INDUCED HYPERTROPHY OF MYOBLASTS INCREASES CYTOSOLIC SIALIDASE NEU2 THROUGH PI-3 KINASE/AKT/mTOR PATHWAY. 107
The expression of Caveolin-3 and its related Limb Girdle Muscular Dystrophy 1-c mutants in myoblasts: physiological and pathological aspects 106
L6E9 Myoblasts Are Deficient of Myostatin and Additional TGF-βMembers Are Candidates to Developmentally Control Their FiberFormation 105
DORSOMORPHIN, A SELECTIVE INHIBITOR OF SMAD1/5/8 PHOSPHORYLATION, IS A POTENT ENHANCER OF MYOBLAST DIFFERENTIATION 105
Intracellular vesicular traffic: identification and expression of zebrafihs APM1 during zebrafish development 103
Developmental expression of the sialidase Neu2 ortholog gene in zebrafish and characterization of the knock-down model. 102
The chemotherapic compound cisplatin causes myotube atrophy by increment of proteasoma activation. 101
Downregulation of Zebrafish Cytosolic Sialidase Neu3.2 Affects Skeletal Muscle Development 100
INDUCTION OF MYOBLAST DIFFERENTIATION BY THE CYTOSOLIC SIALIDASE NEU2 OVEREXPRESSION 100
Differentiation of human rhabdomyosarcoma RD cells is regulated by reciprocal, functional interactions between myostatin, p38 and ERK signalling pathways 99
FUNCTIONAL ANTAGONISM BETWEEN P38 AND MYOSTATIN PATHWAYS IN RHABDOMYOSARCOMA CELLS 94
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines 89
Expression of a myrystoilated Akt1 isoform in rhabdomyosarcoma cells promotes chemo and radioresistance, but confers marked susceptibility to metabolic drug inhibitors 87
Statin-Sensitive Akt1/Src/Caveolin-1 Signaling Enhances Oxidative Stress Resistance in Rhabdomyosarcoma 85
THE MISSENSE CAV-3/P104L MUTATION, INVOLVED IN THE ONSET OF LIMB GIRDLE MUSCULAR DYSTROPHY 1-C, CONFERS AN IMMATURE SIGNATURE TO C2C12 MYOBLASTS 81
Essential Amino Acids-Rich Diet Decreased Adipose Tissue Storage in Adult Mice: A Preliminary Histopathological Study 81
Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation 77
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program 76
miR-449a/miR-340 reprogram cell identity and metabolism in fusion-negative rhabdomyosarcoma 74
Nanostructured Hybrid Polymer-Lipid Drug Delivery Platforms for Rapamycin Repositioning in Anticancer Therapy 73
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks 70
Advances in Nanoparticle Systems for Targeted Therapy against Glioblastoma Multiforme 69
MS-275 (Entinostat) Promotes Radio-sensitivity in PAX3-FOXO1 Rhabdomyosarcoma cells 69
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo 68
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype 67
Phospholipase Cδ-4 (PLCδ4) Acts as a Nuclear Player to Influence Cyclin B Expression in the Embryonal Rhabdomyosarcoma Cell Lines RD and A204 62
The modulation of iron metabolism affects the Rhabdomyosarcoma tumor growth in vitro and in vivo 58
Radioresistance in rhabdomyosarcomas: Much more than a question of dose 57
Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma 56
Statin-Sensitive Akt1/Src/Caveolin-1 Signaling Enhances Oxidative Stress Resistance in Rhabdomyosarcoma 54
Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation 45
Totale 14.677
Categoria #
all - tutte 58.971
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.971


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021233 0 0 0 0 0 0 0 0 0 0 164 69
2021/2022697 40 128 20 14 6 22 48 37 27 97 95 163
2022/2023693 87 24 31 41 60 165 5 63 112 10 39 56
2023/2024817 55 13 108 41 42 159 26 43 177 21 15 117
2024/20252.371 39 10 32 254 197 138 144 64 251 110 844 288
2025/20264.036 413 474 232 514 504 283 702 200 252 338 124 0
Totale 14.738